Results 101 to 110 of about 14,956 (269)
clinical homogeneity and allelic heterogeneity in seven patients [PDF]
Background Larsen syndrome is an autosomal dominant skeletal dysplasia characterized by large joint dislocations and craniofacial dysmorphism. It is caused by missense or small in-frame deletions in the FLNB gene.
Bidchol, Abdul Mueed +9 more
core +1 more source
[Historical review of congenital foot deformity treatment].
There is still no good solution for the treatment of all the forms of clubfoot.The first written description of the treatment of this deformity was given by Hippocrates. In the Middle Ages, Galenus, Celsus and Averroe only reviewed the lessons of Hippocrates's principles.
Mirjana, Petković +4 more
openaire +1 more source
ABSTRACT Objective To determine the diagnostic yield of a nationally implemented first‐trimester anomaly scan (FTAS), compared to standard obstetric care with a second‐trimester anomaly scan. Design Prospective observational cohort study. Setting Nationwide prenatal screening program in the Netherlands.
Kim Bronsgeest +38 more
wiley +1 more source
Is lower-limb alignment associated with hindfoot deformity in the coronal plane? A weightbearing CT analysis [PDF]
Barg, Alexej +6 more
core +1 more source
ABSTRACT Objective To investigate risks of pregnancy and birth in patients with peripheral vascular malformations (VMs). Design Nationwide cross‐sectional study. Setting Tertiary referral centre and Dutch national patient organisation. Population Women aged ≥ 15 years diagnosed with peripheral VM of any subtype or anatomical location.
Delano J. de Oliveira Marreiros +7 more
wiley +1 more source
Long-term Follow up of Van Nes Rotationplasty for Congenital Proximal Focal Femoral Deficiency [PDF]
Van Nes rotationplasty may be used for patients with congenital proximal focal femoral deficiency (PFFD). The lower limb is rotated to use the ankle and foot as a functional knee joint within a prosthesis.
Ackman, Jeffrey D. +8 more
core +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Cardiovascular Health in Women—Across the Lifespan
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
We identify a female patient with a homozygous nonsense variant (p.Gln38Ter) in the LYSET gene. This is the first western report of a challenging case of an extensive diagnostic odyssey and demonstrates that the LYSET gene must be considered in the differential diagnosis when M6P‐labeled lysosomal enzymes are altered.
Fernanda Sperb‐Ludwig +5 more
wiley +1 more source
Category: Midfoot/Forefoot; Diabetes Introduction/Purpose: The complex challenge of reconstructing severe planovalgus deformity of the foot and ankle, often accompanied by subtalar dislocation, is characterized by a heightened risk of lateral wound ...
Firas Raheman MD(Res), MSc(Dist), MRCS +3 more
doaj +1 more source

